Galbraith Kenneth
SEC CIK 1567045 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZYME | Zymeworks Inc. | COB, CEO, Dir | 257.3K | — | $4.45M | 10 | 2024-01-05 | 2026-01-12 |
Most active insiders at ZYME, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Galbraith Kenneth | COB, CEO, Dir | — | $3.34M |
| 2 | Moore Paul Andrew | CSO | — | $721.5K |
| 3 | Smith Jeffrey T L | EVP, Chief Medical Off | — | $475.6K |
| 4 | Hollywood Mark | EVP, COO | — | $138.7K |
| 5 | PATTERSON LEONE D | EVP, Chief Bus, Fin Off | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-12 | 2026-01-12 | ZYME | Zymeworks Inc. | Galbraith Kenneth | COB, CEO, Dir | M - OptEx | $0.00 | +64.0K | 257.3K | +33% | $0 |
| D | 2026-01-12 | 2026-01-12 | ZYME | Zymeworks Inc. | Galbraith Kenneth | COB, CEO, Dir | S - Sale+OE | $22.67 | -30.4K | 226.8K | -12% | -$689.7K |
| DM | 2026-01-05 | 2026-01-05 | ZYME | Zymeworks Inc. | Galbraith Kenneth | COB, CEO, Dir | M - OptEx | $0.00 | +114.3K | 225.0K | +103% | $0 |
| DM | 2026-01-05 | 2026-01-05 | ZYME | Zymeworks Inc. | Galbraith Kenneth | COB, CEO, Dir | S - Sale+OE | $25.10 | -54.3K | 158.3K | -26% | -$1.36M |
| D | 2025-12-22 | 2025-12-22 | ZYME | Zymeworks Inc. | Galbraith Kenneth | COB, CEO, Dir | S - Sale+OE | $27.02 | -47.5K | 133.3K | -26% | -$1.28M |
| D | 2025-12-22 | 2025-12-22 | ZYME | Zymeworks Inc. | Galbraith Kenneth | COB, CEO, Dir | M - OptEx | $0.00 | +100.0K | 180.8K | +124% | $0 |
| DM | 2025-01-06 | 2025-01-06 | ZYME | Zymeworks Inc. | Galbraith Kenneth | COB, CEO, Dir | S - Sale+OE | $14.92 | -57.3K | 80.8K | -41% | -$854.8K |
| DM | 2025-01-06 | 2025-01-06 | ZYME | Zymeworks Inc. | Galbraith Kenneth | COB, CEO, Dir | M - OptEx | $0.00 | +114.3K | 71.4K | New | $0 |
| D | 2024-01-08 | 2024-01-05 | ZYME | Zymeworks Inc. | Galbraith Kenneth | COB, CEO, Dir | M - OptEx | $0.00 | +47.7K | 47.7K | New | $0 |
| DM | 2024-01-08 | 2024-01-05+ | ZYME | Zymeworks Inc. | Galbraith Kenneth | COB, CEO, Dir | S - Sale+OE | $10.79 | -23.9K | 29.5K | -45% | -$257.8K |
Purchase Sale Sale after option exercise All abbreviations